中药材“地区习惯用药”渐趋分化论

论述了中药材“地区习惯用药”的由来与含义,近现代和历史上的“地区习惯用药”的实例以及产生“地区习惯用药”的原因,随品种性质判明而渐趋分化等。最后提出应该积极研究,促其分化,按其本质分类处理的建议。     

Modulation of agonist binding by guanine nucleotides in CHO cells expressing muscarinic m1 – m5 receptors

In membranes prepared from CHO-m2 cells, inhibition of [³H]-N-methylscopolamine ([³H]NMS) binding by several muscarinic agonists resulted in competition curves with Hill slopes significantly different from unity. Addition of 5-guanylylimidodiphosphate (Gpp(NH)p) led to an increase in the IC₅₀ value of the agonists with significant steepening of the inhibition curves. The shift in potency induced by Gpp(NH)p differed among the agonists with a rank order of oxotremorine-M = carbachol > oxotremorine > McN-A-343 = pilocarpine. In CHO-m4 membranes, Gpp(NH)p was less efficacious than in CHO-m2 membranes whereas no effect of the guanine nucleotide was found in membranes prepared from CHO-m1, -m3, and-m5 cells. No major differences in the effect of Gpp(NH)p among agonists were found in CHO-m4 cells. Atropine binding was not affected by the guanine nucleotide. Together, these results indicate that coupling of G-proteins to muscarinic receptors linked to inhibition of cyclic adenosine monophosphate (cAMP) (m2 and m4) but not of those linked to phosphoinositol turnover (m1, m3 and m5) can be perturbed by Gpp(NH)p. The differential effects observed with Gpp(NH)p between agonist binding to m2 and m4 receptors appear to be receptor-specific and may reflect differences in the G proteins activated by these receptors in CHO cells.     

中国地鼠情绪唤醒水平评定量表的制定

为建立一套适合于中国地鼠情绪唤醒水平观测的评定方法,并验证其可靠性,在Ａｄｅｒ 情绪唤醒评定方法基础上进行修订,对中国地鼠进行试测,建立情绪唤醒水平划界分。结果显示总分以５ 分为界,能区分高／ 低情绪唤醒水平的中国地鼠;条目与量表总分呈中高度相关（ ｒ ＝ ０ ．３２６８ ～０ ．７３４７） ,量表总分重测信度良好（ ｒ ＝ ０ ．５８７４ ～０ ．６１０５） ,评定者评分一致性高,符合率达９５－２ ％     

Cancer statistics of Chinese Versus Americans

Cancer incidence and mortality rates of Chinese in China (Shanghai, Kwangtung), Hong Kong, and the United States (San Francisco, etc.) are presented. The rates for the U.S. white population are included for comparison. Additional mortality rates of Chinese in Japan and incidence rates of Chinese in Singapore and British Columbia are also available. Such statistics emphasize both the distinctions and the similarities in cancer problems among chinese living abroad and Chinese living in China. Some ethnic and cultural differences, as well as differences in age, site distribution, and histological subtype, of certain cancers are discussed.     

腰痹舒治疗腰椎间盘突出症临床疗效分析

用中药腰痹舒治疗腰椎间盘突出症 3 1例 ,治愈 2 8例 ,有效 3例。治疗后随访 6～ 1 8个月 ,无 1例复发。与牵引、按摩、秋水仙碱内服对照组比较 ,中药疗效显著优于对照组 (P<0 .0 5 )。经 CT检查 ,腰痹舒治愈后椎间盘的后突压迫、粘连均有不同程度的解除。提出可根据症状、体征将腰椎间盘出症的腰腿痛分为 1 0级。作为判断病情和疗程的主要指标。其治疗宜通经、化瘀散寒为主。     

中医药治疗糖尿病视网膜病变的临床与实验研究近况

综述了近年来中医药治疗糖尿病视网膜病变的研究状况及有待解决的问题。     

反复流产患者的中医护理对策

目的 :探讨结合现代护理观为指导的具有中医特色的整体护理模式。方法 :运用中医基础理论知识 ,针对引起反复流产患者的病因 ,将患者主要分为内分泌异常型、免疫异常型、生殖道异常型、感染型、全身性疾病影响型、染色体异常型施以护理。结果 :依据不同证型 ,有的放矢的实施护理 ,使患者明确了引起反复流产的根本原因、治疗措施、注意事项、预防保健方法 ,消除了紧张、恐惧、焦虑等心理障碍 ,树立了再次妊娠的信心 ,提高了妊娠成功率     

中医药治疗间质性肺病的研究概况

通过对近10年来相关文献的整理和分析，显示中医药对间质性肺病（ILD）防治的研究进展。目前中医学对ILD病症、病因病机以及临床治疗的认识和研究都有了显著的提高，无率是单味中药还是组方用药，其疗效优于单用西药。在延长生存期、改善生存质量、缓解临床症状等方面效果尤为明显。     

436例小儿肺炎的中西医结合治疗

对436例肺炎患儿在抗生素治疗的同时，给予清热宣肺，化痰平喘，健脾益气，养阴清肺中药口服，结果总有效率达97．25％。中西医结合治疗小儿肺炎可以缩短病程，减少抗生素的使用。